Notably, the vaccination of five peptides (CDCA1, URLC10, KIF20A, DEPDC1, and MPHOSPH1) in nine metastatic and advanced BC patients led to immunization locally and systemically in 44% and 78% of patients. Here, LY6K is linked to breast cancer.